TITLE

Study: Most patients who ask for a specific drug get it

PUB. DATE
September 2006
SOURCE
Pharmaceutical Representative;Sep2006, Vol. 36 Issue 9, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that most of the patients in the U.S., who ask their doctor for a specific drug, get it. According to the study jointly conducted by MRxHealth, a medical information provider agency, and the journal "Medical Marketing & Media," 87% of patients get medicines of their choice. The study also revealed that 36% of patients stop taking their medications without informing their doctors. The side effects of medicines were cited as main reason of this tendency.
ACCESSION #
22304126

 

Related Articles

  • What You Don't Know Can Hurt You.  // People's Medical Society Newsletter;Jun2001, Vol. 20 Issue 3, p7 

    Discusses a survey which examined whether patients believe that physicians should use discretion in giving information about the side effects of the medication they prescribe.

  • Death of the silent witness. Iheanacho, Ike // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/2/2011, Vol. 343 Issue 7813, p48 

    The article presents the author's view on the development of direct patient reporting. The author states that patient must have the power to notify directly drug regulators about suspected unwanted effects. The author mentions that the raw information on the unwanted effects is sifted by...

  • The power of suggestion doesn't induce drug side effects.  // Modern Medicine;Apr95, Vol. 63 Issue 4, p37 

    Presents an abstract of the study `Can physicians warn patients of potential side effects without fear of causing those side effects?' by G.C. Lamb et al from the December 12, 1995 issue of the journal `Archives of Internal Medicine.'

  • Patients may not be revealing drug complications.  // Family Practice Management;May2000, Vol. 7 Issue 5, p27 

    Discloses findings of a study conducted by Brigham and Women's Hospital in Boston, Massachusetts, showing that many doctors remain ignorant of adverse reactions suffered by patients from prescription drugs due to a lack of patient-physician communication. Drugs most commonly associated with...

  • EINE UNTERSUCHUNG UBER DIE MEDIKATION UND DIE EINNAHMEWEISE DER MEDIKAMENTE IM GESPRÄCH ZWISCHEN ARZT UND PATIENT. DUMAN, Seyyare // Selcuk University Social Sciences Institute Journal;2008, Vol. 20, p355 

    This case study focuses on physicians' prescription of drugs after an examination and their explanations about how to use the drugs. The study is based on 20 speeches collected from four different clinics. The contents of transcribed speeches were analyzed. The transcription shows that...

  • Helping patients discuss CINV management: development of a Patient Charter. Young, Annie; Dielenseger, Pascale; Ortega, Paz Fernandez; Perez, Dolores Fernandez; Jones, Philippa; Lennan, Elaine; O'Donovan, Eileen; Sharp, Sue; Whiteford, Alison; Wiles, Lilian // Ecancermedicalscience;2013, Vol. 7 Issue 286-298, p1 

    In April 2012, an Expert Group of specialist cancer nurses working in a variety of settings (e.g. chemotherapy delivery, chemotherapy service design, research, nurse leadership and patient information/advocacy) participated in telephone/web-based meetings, with the aim of sharing current...

  • 3 GPs' views. Hall, Chris; Imm, Nick; Cembrowicz, Stefan // Pulse;10/27/2003, Vol. 63 Issue 43, p40 

    Presents the authors' views as physicians on how they would deal with a case in which an obese woman with hypertension takes a combination of thyroxine, sibutramine and dexfenfluramine to lose weight. Hypertensive side effects of the medications; Criticism of doctors who work in so-called diet...

  • Nanotechnology-Enabled Dietary Supplements. O'Mathúna, Dónal P. // Alternative Medicine Alert;Jun2010, Vol. 13 Issue 6, p61 

    The article considers the safety of dietary supplements containing nanoparticles. It mentions that it is important for manufacturers of these supplements to know the potential risks as well as the uncertainty about the side effects of the production of nanoceuticals. Clinicians should also...

  • Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Devereaux, PJ; Anderson, David R; Gardner, Martin J; Putnam, Wayne; Flowerdew, Gordon J; Brownell, Brenda F; Nagpal, Seema; Cox, Jafna L; Fahey, Tom // BMJ: British Medical Journal (International Edition);11/24/2001, Vol. 323 Issue 7323, p1218 

    Abstract Objective: To determine and compare physicians' and patients' thresholds for how much reduction in risk of stroke is necessary and how much risk of excess bleeding is acceptable with antithrombotic treatment in people with atrial fibrillation. Design: Prospective observational study....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics